5-(2-Amino-1-hydroxyethyl)-1,2,4-benzenetriol | 2623-77-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 5-(2-Amino-1-hydroxyethyl)-1,2,4-benzenetriol
• 英文别名: 5-(2-amino-1-hydroxyethyl)benzene-1,2,4-triol
• CAS: 2623-77-0
• 化学式: C₈H₁₁NO₄
• 分子量: 185.18
• InChiKey: QZCMNBHCNQBLDD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  107
• 氢给体数：
  5
• 氢受体数：
  5

文献信息

• Oxygen permeable polymers, ionomers and methods of making the same
  申请人：Nissan North America, Inc.

  公开号：US10259894B1

  公开（公告）日：2019-04-16

  An oxygen permeable polymer has the following formula: wherein RS is a non-sulfonyl halide portion of a sulfonyl halide monomer or polymer; XP is —NH or —NHCO; A is an optionally substituted alkyl; L is 0, 1 or 2; m is 2 or 3; Z is H or CH3; and n is 5-m. The polymer can be used in air separation devices, air concentrators, and in electrodes for electrochemical devices.

  透氧聚合物的分子式如下 其中 RS 是磺酰卤单体或聚合物的非磺酰卤部分；XP 是-NH 或-NHCO；A 是任选取代的烷基；L 是 0、1 或 2；m 是 2 或 3；Z 是 H 或 CH3；n 是 5-m。这种聚合物可用于空气分离装置、空气浓缩器和电化学装置的电极。
• METHOD FOR ANALYSING METABOLITES
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP1695088B1

  公开（公告）日：2012-04-18
• Method for analysing metabolites
  申请人：Ludemann Alexander

  公开号：US20070141712A1

  公开（公告）日：2007-06-21

  Described is a method for analysing the metabolites of a biological sample which comprises quantitatively determining one or more metabolites in said sample in a way that said quantitative determination resolves isotopic mass differences within one metabolite, said method being characterized in that the sample comprises or is derived from a cell which has been maintained under conditions allowing the uptake of an isotopically labeled metabolizable compound so that the metabolites in said cell are saturated with the isotope with which said metabolizable compound is labeled. This method may further comprise, prior to quantitative determining the metabolites, combining the biological sample (i.e. the first biological sample) with a second biological sample in which the metabolites are not isotopically labeled or are isotopically labeled differently from the first biological sample; and determining in said biological samples the relative quantity of metabolites which differ by their isotopical label. Furthermore described is a set of isotopically labeled metabolites obtainable by applying this method, as well as kits facilitating the application of this method and corresponding uses.
• Oxygen Permeable Monomers, Polymers and Ionomers and Methods of Making the Same
  申请人：Nissan North America, Inc.

  公开号：US20190092882A1

  公开（公告）日：2019-03-28

  An oxygen permeable polymer has the following formula: wherein R S is a non-sulfonyl halide portion of a sulfonyl halide monomer or polymer; X P is —NH or —NHCO; A is an optionally substituted alkyl; L is 0, 1 or 2; m is 2 or 3; Z is H or CH 3 ; and n is 5−m. The polymer can be used in air separation devices, air concentrators, and in electrodes for electrochemical devices.
• [EN] METHOD FOR ANALYSING METABOLITES<br/>[FR] PROCEDE D'ANALYSE DE METABOLITES
  申请人：MAX PLANCK GESELLLSCHAFT ZUR F

  公开号：WO2005059556A1

  公开（公告）日：2005-06-30

  Described is a method for analysing the metabolites of a biological sample which comprises quantitatively determining one or more metabolites in said sample in a way that said quantitative determination resolves isotopic mass differences within one metabolite, said method being characterized in that the sample comprises or is derived from a cell which has been maintained under conditions allowing the uptake of an isotopically labeled metabolizable compound so that the metabolites in said cell are saturated with the isotope with which said metabolizable compound is labeled. This method may further comprise, prior to quantitative determining the metabolites, combining the biological sample (i.e. the first biological sample) with a second biological sample in which the metabolites are not isotopically labeled or are isotopically labeled differently from the first biological sample; and determining in said biological samples the relative quantity of metabolites which differ by their isotopical label. Furthermore described is a set of isotopically labeled metabolites obtainable by applying this method, as well as kits facilitating the application of this method and corresponding uses.